CLINICAL_TRIALS trial_result · 2020-09-03

Clinical Trial Update: Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis [Phase 4]

Phase 4 trial assessing changes in the immune profile in adults with early rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2020-09-03